Extendicare Inc (EXETF) 7.0600 $EXETF Extendicare

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Extendicare Inc (EXETF) 7.0600 $EXETF

Extendicare Announces September 2016 Dividend of C$0.04 per Share
Marketwire Canada - Thu Sep 15, 7:02AM CDT
MARKHAM, ON--(Marketwired - September 15, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share" for the month of September 2016, which is payable on October 17, 2016 to shareholders of record at the close of business on September 30, 2016. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
EXE.TO: 9.28 (+0.13)

Extendicare Announces Solid 2016 Second Quarter Results
Marketwire Canada - Thu Aug 11, 4:00PM CDT
MARKHAM, ON--(Marketwired - August 11, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today reported results for the three and six months ended June 30, 2016. Results are presented in Canadian dollars unless otherwise noted.
EXE.TO: 9.28 (+0.13)

Extendicare Announces Voting Results From the 2016 Annual and Special Meeting of Shareholders
Marketwired - Fri May 27, 6:05PM CDT
MARKHAM, ON--(Marketwired - May 27, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced the results of matters voted on at its annual and special shareholders' meeting held on May 26, 2016 (the "Meeting", which included the election as directors of the Company, all of the nominees listed in its management information and proxy circular dated April 8, 2016 (the "Information Circular". The voting results for each of the matters presented at the Meeting are presented below.
EXE.TO: 9.28 (+0.13)

Extendicare Announces 2016 First Quarter Results
Marketwire Canada - Thu May 12, 4:00PM CDT
MARKHAM, ON--(Marketwired - May 12, 2016) - Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today reported results for the first quarter ended March 31, 2016. Results are presented in Canadian dollars unless otherwise noted.
EXE.TO: 9.28 (+0.13)

Extendicare Announces Expansion of Home Health Care Business Into Vancouver Coastal Health Authority
Marketwired - Fri Apr 29, 5:27PM CDT
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) is pleased to announce the continued growth of its home health care business with an expansion into the Vancouver Coastal Health Authority.
EXE.TO: 9.28 (+0.13)

Extendicare Announces April 2016 Dividend of C$0.04 per Share
Marketwired - Fri Apr 15, 7:00AM CDT
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share" for the month of April 2016, which is payable on May 16, 2016 to shareholders of record at the close of business on April 29, 2016. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
EXE.TO: 9.28 (+0.13)

Extendicare Announces Timing of 2015 Year End Results and Conference Call
Marketwire Canada - Mon Jan 25, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced it will release its financial results for the fourth quarter and year ended December 31, 2015, on Thursday, February 25, 2016, and will host a conference call and live audio webcast on Friday, February 26, 2016, at 9:00 a.m. (ET) to discuss the results.
EXE.TO: 9.28 (+0.13)

Extendicare Reaches Agreement With Oxford Park Group and Announces Changes to its Board of Directors
Marketwired - Fri Jan 22, 6:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announces that it has reached an agreement with Oxford Park Group ("Oxford Park" that is in the best interests of all of Extendicare's shareholders and other stakeholders, which enables the Company to avoid what could have been an expensive and distracting proxy contest. Pursuant to the terms of the agreement, among other items:
EXE.TO: 9.28 (+0.13)

Extendicare Announces January 2016 Dividend of C$0.04 per Share
Marketwired - Fri Jan 15, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the "Common Share" for the month of January 2016, which is payable on February 16, 2016 to shareholders of record at the close of business on January 29, 2016. This dividend is designated as an "eligible dividend" within the meaning of the Income Tax Act (Canada).
EXE.TO: 9.28 (+0.13)

Extendicare Announces Changes to Its Board of Directors
Marketwired - Wed Jan 06, 7:02AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announces several changes to its Board of Directors, resulting from the board renewal process commenced in August 2015 following completion of the sale of the Company's U.S. operations. The objective of the process was to review the Board's composition to ensure that it continues to have the ideal mix of skills, experience and perspectives to oversee management's implementation of Extendicare's strategic plan.
EXE.TO: 9.28 (+0.13)

Extendicare Normal Course Issuer Bid Approved by TSX
Marketwired - Wed Dec 30, 7:00AM CST
Extendicare Inc. ("Extendicare" or the "Company" (TSX: EXE) today announced that it has received the approval of the Toronto Stock Exchange (the "TSX" to renew its normal course issuer bid (the "Bid" for up to 8,610,000 of its common shares (the "Common Shares" through the facilities of the TSX, and on alternative Canadian trading systems.
EXE.TO: 9.28 (+0.13)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BioVersys AlpE Data Offers a Measured TB Treatment Signal

Updated Category News Views 0

Tuberculosis drug development rarely hands anybody a clean victory lap, and BioVersys' latest readout is no exception. The completed 14-day Phase 2a ENABLE study gives alpibectir plus ethionamide, known as AlpE, a credible early clinical signal in newly diagnosed drug-sensitive pulmonary TB. That matters. It does not, however, settle the far larger question of whether...

Continue Reading
&honey's U.S. Beauty Awards Sweep Puts Distribution in Focus

Updated Category News Views 128

Three glossy-magazine nods may sound fluffy, but shelf momentum is never entirely fluff. Japanese haircare brand &honey says its Deep Moist Shampoo, Treatment and Hair Oil each landed 2026 recognition from Marie Claire, ELLE and Allure. For a consumer brand trying to make an American habit out of a Japanese haircare ritual, that is the sort of validation worth...

Continue Reading
Jeff Stern Turns Travel Photography Into Full Attention

Updated Category News Views 57

A cancelled photography conference in March 2020 sent Jeff Stern toward the American Southwest, and that detour eventually became A Change of Scenery. Frankly, that origin has more grit than the usual polished creative-origin tale. While much of the world had stopped moving, Stern went alone, stood at White Pocket beneath a cobalt sky, and began reconsidering what he...

Continue Reading
Movement Elevates a Longtime Insider as Its New CEO

Updated Category News Views 81

Chalk dust rarely makes headlines, yet this is the sort of leadership change that can decide whether a consumer brand keeps its footing. Movement Climbing, Yoga and Fitness named Ryan Sewell chief executive officer effective November 18, 2026, with Anne-Worley Moelter moving into the chairperson role. It is a conspicuously internal handoff: Sewell started at the Boulder...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 158

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Yunnan Tin’s AI Materials Push Has Real Operating Teeth

Updated Category News Views 66

Tin rarely gets the spotlight until the machinery behind modern computing starts demanding more of it. Yunnan Tin Group is making the sensible case that this unglamorous metal can matter a great deal in semiconductors, artificial intelligence infrastructure and new-energy hardware. There is plenty of corporate ambition wrapped around that case, naturally, but a few...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 30

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading
Ajman Forum Puts Trust at the Center of Crisis Media

Updated Category News Views 82

Rumours do not wait politely for a communications team to finish its meeting. That plain reality sat underneath Abdulla bin Mohammed bin Butti Al Hamed's keynote at Ajman Media Forum 2026, and it is a tougher point than the usual talk about reach, engagement, or flashy new technology. In a crisis, an information vacuum gets filled fast, usually by somebody with no...

Continue Reading
NKT’s Q3 Margin Holds Up as Capacity Spending Bites

Updated Category News Views 119

Steel, copper and giant cable drums do not make for a pretty quarterly story, but NKT’s numbers have a sturdier backbone than the headline revenue dip suggests. The company delivered EUR 111 million of operational EBITDA in Q3 2026, down from EUR 119 million a year earlier, while its margin at standard metal prices edged up to 16.6% from 16.4%. That is not fireworks. It...

Continue Reading
Caliway's China Clearance Speeds CBL-514's Next Test

Updated Category News Views 18

China's regulator moved faster than the calendar, and that is the one detail worth circling in red ink. Caliway Biopharmaceuticals has received authorization from the Center for Drug Evaluation under China's National Medical Products Administration to begin CBL-0102, its China study of injectable fat-reduction candidate CBL-514. For a clinical-stage company, an...

Continue Reading

Top 5 Most Recently Viewed Articles

Immuron Advances IMM-529 Development Following FDA Feedback

Updated Category News Views 289

Immuron Charts Path for Phase 2 Trial of IMM-529 Key Highlights Immuron concludes an important pre-IND meeting with the FDA regarding IMM-529, aimed at combating Clostridioides difficile infection (CDI). Previous clinical trials highlight the necessity for ongoing development of IMM-529. The company plans to submit an IND application for IMM-529 in the first half of 2025.

Continue Reading
Enefit Green to Host Webinars for Unveiling 2024 Results

Updated Category News Views 123

Join Enefit Green's Upcoming Webinars on 2024 Results Enefit Green is set to announce its Q4 and annual unaudited results for 2024. The special reveal will occur shortly after the publication of the report, allowing shareholders and investors to gain critical insights into the company's financial standing. Webinar Schedule and Details The webinars will be hosted on the...

Continue Reading
Intapp's Encouraging Earnings Fuel Stock Surge Amid Market Momentum

Updated Category News Views 197

Intapp's Strong Earnings Report Captivates Investors On a positive note for investors, U.S. stocks saw an uplifting day, with the Dow Jones index climbing approximately 250 points. The highlight of the day was the impressive performance of Intapp, Inc. Shares of Intapp, Inc. (NASDAQ: INTA) experienced a sharp increase following the company's announcement of...

Continue Reading
NewAmsterdam Pharma's Upcoming Conference Participation for 2024

Updated Category News Views 229

NewAmsterdam Pharma Announces Conference Participation NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS) is gearing up for an exciting lineup of presentations at key medical and investor conferences. As a leader in developing innovative oral therapies for cardiovascular disease, NewAmsterdam is set to share groundbreaking research findings and engage with stakeholders in...

Continue Reading
John Hancock Funds Announce Monthly Distribution Updates

Updated Category News Views 366

Monthly Distribution Announcements from John Hancock Funds John Hancock has announced important updates regarding the distributions for its closed-end funds. These monthly distributions aim to provide returns to investors, ensuring they receive value from their investments in a timely manner. Details of the Monthly Distribution Declaration Key Dates Recently, the board of...

Continue Reading